D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 49.06 EUR 1.93% Market Closed
Market Cap: 4B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

D05 Price Targets Summary
Deciphera Pharmaceuticals Inc

There are no price targets for D05.
D05 Lowest Forecast
Wall Street Target
Not Available
D05 Average Forecast
Wall Street Target
Not Available
D05 Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Deciphera Pharmaceuticals Inc Competitors:
Price Targets
KMDA
Kamada Ltd
95% Upside
E
1952
Everest Medicines Ltd
14% Downside
ARQT
Arcutis Biotherapeutics Inc
46% Upside
RNA
Avidity Biosciences Inc
83% Upside
KMDA
Kamada Ltd
95% Upside
E
1952
Everest Medicines Ltd
14% Downside
ARQT
Arcutis Biotherapeutics Inc
46% Upside
RNA
Avidity Biosciences Inc
83% Upside
RIGL
Rigel Pharmaceuticals Inc
71% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
1% Downside
AKBA
Akebia Therapeutics Inc
112% Upside
M
086900
Medy Tox Inc
41% Upside

Revenue
Forecast

Revenue Estimate
Deciphera Pharmaceuticals Inc

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 1 year is 12%.

N/A
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Deciphera Pharmaceuticals Inc

Operating Income forecast
is not available for
Deciphera Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Deciphera Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
D05 intrinsic value, competitors valuation, and company profile.
DCF Valuation
D05 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
D05 stock valuation using valuation multiples.
Wall Street Estimates
D05 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
D05 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is D05's stock price target?
Not Available

D05 doesn't have any price targets made by Wall Street professionals.

What is Deciphera Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
12%

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 1 year is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 270,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.